DOI: 10.1111/apt.17770 ISSN: 0269-2813

Letter: Comparing first‐line infliximab and vedolizumab for ulcerative colitis—it depends on how you use the drug

Danny Con, Ashish Srinivasan
  • Pharmacology (medical)
  • Gastroenterology
  • Hepatology
Show PDF Cite

LINKED CONTENT

This article is linked to Bokemeyer et al papers. To view these articles, visit https://doi.org/10.1111/apt.17616 and https://doi.org/10.1111/apt.17796

More from our Archive